The Foundation for the National Institutes of Health (FNIH) will present the 2026 Charles A. Sanders, MD, Partnership Award to Dan Doctoroff, founder of Target ALS; Biogen; and the National Institutes of Health’s (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This award recognizes significant contributions to the FNIH's mission in support of NIH. Julie Gerberding, FNIH President and CEO, emphasized the importance of partnerships in advancing biomedical research. Doctoroff's efforts in creating the ALS Knowledge Portal under the Accelerating Medicines Partnership (AMP) have been pivotal for ALS research. Biogen has been a steadfast partner for 15 years, contributing to various initiatives in immunology and neuroscience. NIAMS has been instrumental in the AMP program, which aims to transform the development of diagnostics and treatments. The awards will be presented at the 14th Annual FNIH Awards Ceremony on October 28, 2026, in Washington, D.C., alongside other prestigious awards.